NO20032332D0 - Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav - Google Patents

Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav

Info

Publication number
NO20032332D0
NO20032332D0 NO20032332A NO20032332A NO20032332D0 NO 20032332 D0 NO20032332 D0 NO 20032332D0 NO 20032332 A NO20032332 A NO 20032332A NO 20032332 A NO20032332 A NO 20032332A NO 20032332 D0 NO20032332 D0 NO 20032332D0
Authority
NO
Norway
Prior art keywords
preparation
derivative compounds
benzodiazepine derivative
benzodiazepine
compounds
Prior art date
Application number
NO20032332A
Other languages
English (en)
Other versions
NO20032332L (no
Inventor
Juan Carlos Del Castillo Nieto
Berta Esperanza Lasheras Aldaz
Antonio Monge Vega
Marisabel Mourelle Mancini
Joaquin Del Rio Zambrana
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Publication of NO20032332D0 publication Critical patent/NO20032332D0/no
Publication of NO20032332L publication Critical patent/NO20032332L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
NO20032332A 2000-11-29 2003-05-22 Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav NO20032332L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200002914A ES2188344B1 (es) 2000-11-29 2000-11-29 Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
PCT/IB2001/002211 WO2002044170A2 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof

Publications (2)

Publication Number Publication Date
NO20032332D0 true NO20032332D0 (no) 2003-05-22
NO20032332L NO20032332L (no) 2003-05-22

Family

ID=8495887

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032332A NO20032332L (no) 2000-11-29 2003-05-22 Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav

Country Status (35)

Country Link
US (1) US20040034219A1 (no)
EP (1) EP1337528B1 (no)
JP (1) JP2004514719A (no)
KR (1) KR20030066689A (no)
CN (1) CN1478088A (no)
AP (1) AP2003002801A0 (no)
AR (1) AR034009A1 (no)
AT (1) ATE272634T1 (no)
AU (1) AU2002215157A1 (no)
BG (1) BG107851A (no)
BR (1) BR0115708A (no)
CA (1) CA2429892A1 (no)
CZ (1) CZ20031398A3 (no)
DE (1) DE60104717T2 (no)
EA (1) EA200300519A1 (no)
EE (1) EE200300245A (no)
ES (2) ES2188344B1 (no)
GE (1) GEP20043366B (no)
HR (1) HRP20030407A2 (no)
HU (1) HUP0303568A3 (no)
IL (1) IL155966A0 (no)
IS (1) IS6824A (no)
MA (1) MA26963A1 (no)
MX (1) MXPA03004875A (no)
NO (1) NO20032332L (no)
NZ (1) NZ525950A (no)
OA (1) OA12536A (no)
PE (1) PE20020692A1 (no)
PL (1) PL362982A1 (no)
PT (1) PT1337528E (no)
SI (1) SI1337528T1 (no)
SK (1) SK6202003A3 (no)
TR (1) TR200402779T4 (no)
WO (1) WO2002044170A2 (no)
ZA (1) ZA200303858B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
US7452888B2 (en) 2002-03-27 2008-11-18 Glaxo Group Limited Quinoline derivatives and their use as 5-ht6 ligands
BRPI0406748A (pt) 2003-01-13 2005-12-20 Dynogen Pharmaceuticals Inc Método de tratamento de náusea, vÈmito e ânsia de vÈmito ou qualquer combinação destes em um paciente que necessite do mesmo e composição farmacêutica
US7276603B2 (en) 2003-05-02 2007-10-02 Wyeth Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
TW200523253A (en) 2003-07-22 2005-07-16 Arena Pharm Inc Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
DE102004023506A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023635A1 (de) * 2004-05-10 2006-04-13 Grünenthal GmbH Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023632A1 (de) * 2004-05-10 2005-12-08 Grünenthal GmbH Substituierte Cyclohexylcarbonsäure-Derivate
DE102004023501A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Oxosubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023522A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023508A1 (de) * 2004-05-10 2005-12-08 Grünenthal GmbH Säurederivate substituierter Cyclohexyl-1,4-diamine
DE102004023507A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexylessigsäure-Derivate
US7881267B2 (en) * 2004-06-04 2011-02-01 Hewlett-Packard Development Company, L.P. Portable computing device for wireless communications and method of operation
DE102004063797A1 (de) * 2004-12-30 2006-07-13 Schwarz Pharma Ag Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
WO2009074607A1 (en) 2007-12-12 2009-06-18 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
CN101619056B (zh) 2008-07-02 2013-07-17 石药集团中奇制药技术（石家庄）有限公司 苯并噻吩烷醇哌嗪衍生物及其作为抗抑郁症药物的应用
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
WO2015014256A1 (en) 2013-07-29 2015-02-05 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
MX2017016413A (es) 2015-06-12 2018-08-01 Axovant Sciences Gmbh Derivados de diaril y arilheteroaril urea como moduladores del receptor 5ht2a de serotonina útiles para la profilaxis y el tratamineto de un trastorno conductual del sueño rem.
CA2992518A1 (en) 2015-07-15 2017-01-19 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
US5693804A (en) * 1994-11-17 1997-12-02 Molecular Geriatrics Corporation Substituted 1-aryl-3-piperazin-1'-yl propanones
US5658909A (en) * 1994-11-17 1997-08-19 Molecular Geriatrics Corporation Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease
ES2128266B1 (es) * 1997-07-08 2000-01-16 Vita Invest Sa Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes.

Also Published As

Publication number Publication date
US20040034219A1 (en) 2004-02-19
HUP0303568A2 (hu) 2004-03-01
PT1337528E (pt) 2004-11-30
ES2188344A1 (es) 2003-06-16
CZ20031398A3 (cs) 2004-01-14
ZA200303858B (en) 2004-05-19
EP1337528B1 (en) 2004-08-04
EP1337528A2 (en) 2003-08-27
NZ525950A (en) 2004-11-26
IS6824A (is) 2003-05-22
DE60104717D1 (de) 2004-09-09
DE60104717T2 (de) 2006-04-06
PL362982A1 (en) 2004-11-02
AP2003002801A0 (en) 2003-06-30
ATE272634T1 (de) 2004-08-15
CA2429892A1 (en) 2002-06-06
MXPA03004875A (es) 2005-02-14
TR200402779T4 (tr) 2004-11-22
WO2002044170A2 (en) 2002-06-06
EE200300245A (et) 2003-08-15
AU2002215157A1 (en) 2002-06-11
EA200300519A1 (ru) 2003-12-25
NO20032332L (no) 2003-05-22
GEP20043366B (en) 2004-04-13
OA12536A (en) 2006-06-05
HRP20030407A2 (en) 2004-08-31
JP2004514719A (ja) 2004-05-20
CN1478088A (zh) 2004-02-25
SI1337528T1 (en) 2005-02-28
BR0115708A (pt) 2004-02-03
HUP0303568A3 (en) 2005-02-28
ES2225623T3 (es) 2005-03-16
BG107851A (bg) 2004-06-30
IL155966A0 (en) 2003-12-23
AR034009A1 (es) 2004-01-21
KR20030066689A (ko) 2003-08-09
SK6202003A3 (en) 2004-05-04
PE20020692A1 (es) 2002-09-02
ES2188344B1 (es) 2004-09-16
WO2002044170A3 (en) 2002-09-06
MA26963A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
NO20032332D0 (no) Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
IS7188A (is) Asabísýklísk-setin samtengd heteróarýl efnasambönd, aðferð til framleiðslu þeirra og notkun
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
EE05387B1 (et) KinasoliiniÁderivaadid,ÁnendeÁvalmistamismeetodÁjaÁkasutamine
NO20035325D0 (no) Hudpermeabelt selektiv cyklooksygenase-2-inhibitorpreparat
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DK1339292T3 (da) Sammensætning og fremgangsmåde
NO20031152D0 (no) Befruktningshindrende fremgangsmåte og administrasjonsform for det samme
NO20021736L (no) Nytt preparat og fremgangsmåte for stabilisering av det
IS6531A (is) Aðferðir til að búa til klaríþrómýsín og klaríþrómýsínmilliefni, í megindráttum oxímlaust klaríþrómýsín og lyfjablanda sem inniheldur það
NO20041058L (no) Preparater og fremgangsmater relatert til nye benzodiazepinforbindelser og mal derav
IS2821B (is) Amínóalkýlbensóýl-bensófúran eða bensóþíófenafleiður, aðferð til framleiðslu þeirra og samsetningar sem innihalda þær
DK1334106T3 (da) Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
NO20031691D0 (no) Telekommunikasjonsnettverk og fremgangsmåte for betjening av nettverket
NO20013735L (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
IS2331B (is) 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra
NO20021947D0 (no) Bio-b¶rende matrikser, fremgangsmåte for fremstilling og anvendelse derav
DK1282639T3 (da) Polyamidnucleinsyrederivater, midler og fremgangsmåder til fremstilling heraf
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
NO20031108L (no) Farmasöytisk preparat for behandling av hodepine, og fremgangsmåte for fremstilling av preparatet
NO20000290D0 (no) Isolasjonssystem, fremgangsmåte for isolering og anvendelse av isolasjonssystem
NO20024105D0 (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application